RAFAEL ALBERTO
LÓPEZ ZORZANO
Profesor contratado doctor
David Geffen School of Medicine at UCLA
Los Ángeles, Estados UnidosPublicaciones en colaboración con investigadores/as de David Geffen School of Medicine at UCLA (1)
2018
-
Paclitaxel with inhibitor of apoptosis antagonist, LCL161, for localized triple-negative breast cancer, prospectively stratified by gene signature in a biomarker-driven neoadjuvant trial
Journal of Clinical Oncology, Vol. 36, Núm. 31, pp. 3126-3133